Overview
Congenital laryngomalacia, also known as congenital laryngeal stridor, is the most common congenital anomaly of the larynx (voice box) and the most frequent cause of stridor (noisy breathing) in newborns and infants. The condition is characterized by an abnormally soft and floppy supraglottic laryngeal tissue — particularly the epiglottis, aryepiglottic folds, and arytenoid cartilages — which collapse inward during inspiration, partially obstructing the airway. This results in the hallmark symptom of inspiratory stridor, which is typically high-pitched and worsens with feeding, crying, agitation, or when the infant is placed in a supine position. The condition primarily affects the upper airway and respiratory system, though secondary effects on feeding and growth can occur. Key clinical features include intermittent inspiratory stridor that usually appears within the first two weeks of life, feeding difficulties, gastroesophageal reflux, and in more severe cases, failure to thrive, obstructive apnea, cyanotic episodes, and pectus excavatum due to chronic increased respiratory effort. Diagnosis is confirmed by flexible laryngoscopy, which reveals the characteristic collapse of supraglottic structures during inspiration. The majority of cases (approximately 90%) are mild to moderate and resolve spontaneously by 12 to 24 months of age as the laryngeal cartilage matures and stiffens. Conservative management includes upright positioning during and after feeds, anti-reflux measures, and close monitoring of growth and respiratory status. For the approximately 10% of infants with severe laryngomalacia — characterized by significant feeding difficulties, failure to thrive, oxygen desaturation, or obstructive apnea — surgical intervention with supraglottoplasty is the standard treatment. This procedure involves trimming redundant supraglottic tissue and has a high success rate. The exact etiology remains incompletely understood, though neuromuscular immaturity, anatomical factors, and gastroesophageal reflux disease are thought to play contributing roles.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital laryngomalacia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital laryngomalacia at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital laryngomalacia.
Community
No community posts yet. Be the first to share your experience with Congenital laryngomalacia.
Start the conversation →Latest news about Congenital laryngomalacia
No recent news articles for Congenital laryngomalacia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital laryngomalacia
What is Congenital laryngomalacia?
Congenital laryngomalacia, also known as congenital laryngeal stridor, is the most common congenital anomaly of the larynx (voice box) and the most frequent cause of stridor (noisy breathing) in newborns and infants. The condition is characterized by an abnormally soft and floppy supraglottic laryngeal tissue — particularly the epiglottis, aryepiglottic folds, and arytenoid cartilages — which collapse inward during inspiration, partially obstructing the airway. This results in the hallmark symptom of inspiratory stridor, which is typically high-pitched and worsens with feeding, crying, agitati
How is Congenital laryngomalacia inherited?
Congenital laryngomalacia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Congenital laryngomalacia typically begin?
Typical onset of Congenital laryngomalacia is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Congenital laryngomalacia?
18 specialists and care centers treating Congenital laryngomalacia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.